Dr. Alkhouri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
607 Camden St
Ste 108
San Antonio, TX 78215Phone+1 210-253-3426Fax+1 210-237-4807
Education & Training
Cleveland Clinic FoundationFellowship, Pediatric Gastroenterology, 2007 - 2010
Albert Einstein Medical CenterResidency, Internal Medicine/Pediatrics, 2003 - 2007
Damascus University Faculty of MedicineClass of 2001
Certifications & Licensure
AZ State Medical License 2020 - 2026
OH State Medical License 2007 - 2025
TX State Medical License 2017 - 2025
PA State Medical License 2003 - 2007- American Board of Internal Medicine Internal Medicine
- American Board of Obesity Medicine Obesity Medicine
Clinical Trials
- Mediterranean Diet and Protein-Sparing Modified Diet for Metabolic Syndrome in Liver Transplant Recipients Start of enrollment: 2014 Jun 01
Publications & Presentations
PubMed
- 9 citationsExpert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients With MASH/NASH and Moderate to Noncirrhotic Advanced...Mazen Noureddin, Michael R Charlton, Stephen A Harrison, Meena B Bansal, Naim Alkhouri
Clinical Gastroenterology and Hepatology. 2024-12-01 - Survodutide in MASH: bridging the gap between hepatic and systemic metabolic dysfunction.Eda Kaya, Yusuf Yilmaz, Naim Alkhouri
Expert Opinion on Investigational Drugs. 2024-12-01 - The trends and incidence of alcohol-associated hepatitis hospitalizations from 2016-2020 and the impact of the COVID-19 pandemic.Megan B Ghai, Pooja Rangan, Naim Alkhouri, Jessica Mellinger, Karn Wijarnpreecha
Alcohol. 2024-12-01
Journal Articles
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications for Liver Transplant and Ethnic and Gender VariancesTsuyoshi Todo, Walid S Ayoub, Naim Alkhouri, Nicholas N Nissen, Vinay Sundaram, Shelly C Lu, Mazen Noureddin, Aarshi Vipani, Tram Tran, Andrew S Klein, Nature
Press Mentions
PharmaIN Unveils Interim Phase 1b Clinical Data on the Activity and Safety of PHIN-214 in Decompensated Liver Cirrhosis at AASLD - the Liver Meeting® 2024November 18th, 2024- 89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD the Liver Meeting® 2024November 15th, 2024
- MRI Biomarkers Identify Histologic Improvement in MASHNovember 8th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
